348 related articles for article (PubMed ID: 28333214)
21. Testosterone and the prostate: implications for the treatment of hypogonadal men.
Holyoak JD; Crawford ED; Meacham RB
Curr Urol Rep; 2008 Nov; 9(6):500-5. PubMed ID: 18947516
[TBL] [Abstract][Full Text] [Related]
22. Testosterone replacement therapy and prostate cancer: a word of caution.
Brand TC; Canby-Hagino E; Thompson IM
Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
[TBL] [Abstract][Full Text] [Related]
23. Assessment and management of male androgen disorders: an update.
Chan I; Fui MN; Zajac JD; Grossmann M
Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
[TBL] [Abstract][Full Text] [Related]
24. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
25. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
26. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
Jensen CF; Fode M; Østergren P; Sønksen J
Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152
[TBL] [Abstract][Full Text] [Related]
27. Update on Testosterone Replacement Therapy in Hypogonadal Men.
Leung KM; Alrabeeah K; Carrier S
Curr Urol Rep; 2015 Aug; 16(8):57. PubMed ID: 26077352
[TBL] [Abstract][Full Text] [Related]
28. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.
Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S
Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433
[TBL] [Abstract][Full Text] [Related]
29. Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden.
Arver S; Luong B; Fraschke A; Ghatnekar O; Stanisic S; Gultyev D; Müller E
J Sex Med; 2014 Jan; 11(1):262-72. PubMed ID: 23937088
[TBL] [Abstract][Full Text] [Related]
30. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
[TBL] [Abstract][Full Text] [Related]
31. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
Mäkinen JI; Huhtaniemi I
Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
[TBL] [Abstract][Full Text] [Related]
32. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
33. Testosterone and the aging male: to treat or not to treat?
Bain J
Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946
[TBL] [Abstract][Full Text] [Related]
34. Late-onset hypogonadism.
Bassil N
Med Clin North Am; 2011 May; 95(3):507-23, x. PubMed ID: 21549875
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
[TBL] [Abstract][Full Text] [Related]
36. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
37. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
Turchi P; Simi S; Pescatori ES
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
[TBL] [Abstract][Full Text] [Related]
38. Testosterone replacement therapy and cardiovascular events.
Çatakoğlu AB; Kendirci M
Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
[TBL] [Abstract][Full Text] [Related]
39. Androgen therapy in the aging male.
Lunenfeld B
World J Urol; 2003 Nov; 21(5):292-305. PubMed ID: 14576959
[TBL] [Abstract][Full Text] [Related]
40. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
Afiadata A; Ellsworth P
Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
